Abstract

There have been important updates in the guidelines for the management of agitation in emergency room settings, including psychiatric emergency services. This manuscript provides a synthesis of current recommendations for managing agitation, combined with a detailed breakdown of the neurobiology of agitation, linking these neurobiological dimensions with the mechanisms of action and relevant pharmacodynamic / pharmacokinetic profiles of the drugs that were presented in the guidelines (as well as some important agents that might not be included). Since Project BETA (Best Practices in Evaluation and Treatment of Agitation) published its guidelines in 2012, there have been several developments in the standard of care, including an increased use of ketamine and droperidol. Updated guidelines provided by The American College of Emergency Physicians (ACEP) will also be reviewed.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.